Search

everythinglearnresearchcommunity

for

Search:↓

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

HSPGs help control stem cell behavior, affecting hair growth and offering a target for hair loss treatments.

Exosomes could be a promising way to help repair skin and treat skin disorders.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The fascial layer is a promising new target for wound healing treatments using biomaterials.

New understanding and treatments for hair loss are improving, but more research is needed.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

TGM3 is important for skin and hair structure and may help diagnose cancer.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Notch1 signaling is crucial for improving wound healing and skin regeneration by affecting stem cell behavior.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

Notch signaling disruptions can cause various skin diseases.

Exosomes could be key in treating skin conditions and healing wounds.

Both human and animal-derived small extracellular vesicles speed up skin healing equally well.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Hair can regrow after certain stem cells are lost because other stem cells can take over their role.

The 3D electrospun fibrous sponge is promising for tissue repair and healing diabetic wounds.

Scientists found a new, less invasive way to get stem cells from horse hair for veterinary medicine.